tobramycin has been researched along with Communicable Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, Z; Fan, X; Liu, X; Mi, Z; Wen, H; Zhang, H; Zhang, Y | 1 |
| Hannakan, CJ; Jackson, RJ; Rowe, MI; Smith, SD; Tzakis, AG; Wadowsky, RM | 1 |
1 trial(s) available for tobramycin and Communicable Diseases
| Article | Year |
|---|---|
Selective decontamination in pediatric liver transplants. A randomized prospective study.
Topics: Adolescent; Amphotericin B; Child; Child, Preschool; Communicable Diseases; Digestive System; Female; Humans; Infant; Liver Transplantation; Male; Mycoses; Polymyxins; Prospective Studies; Tobramycin; Virus Diseases | 1993 |
1 other study(ies) available for tobramycin and Communicable Diseases
| Article | Year |
|---|---|
Anti-Biofilm Enzymes-Assisted Antibiotic Therapy against Burn Wound Infection by Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Burns; Communicable Diseases; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Wound Infection | 2023 |